Amphastar Pharmaceuticals, Inc. financial data

Symbol
AMPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
11570 Sixth Street, Rancho Cucamonga, California
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 199 % -47.7%
Quick Ratio 44 % -56.3%
Return On Equity 24.8 % +38.5%
Return On Assets 10.3 % -18.1%
Operating Margin 31.3 % +36%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.9M shares +1.3%
Common Stock, Shares, Outstanding 48.8M shares +1.37%
Entity Public Float 1.49B USD +68%
Common Stock, Value, Issued 6K USD 0%
Weighted Average Number of Shares Outstanding, Basic 48.2M shares +0.44%
Weighted Average Number of Shares Outstanding, Diluted 53M shares +2.01%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 676M USD +30.4%
Cost of Revenue 309M USD +22.7%
Research and Development Expense 71M USD -9.44%
Selling and Marketing Expense 31.1M USD +34.6%
General and Administrative Expense 53.7M USD +16.6%
Operating Income (Loss) 212M USD +77.3%
Nonoperating Income (Expense) -25.9M USD -2155%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 186M USD +54%
Income Tax Expense (Benefit) 29.2M USD +11.7%
Net Income (Loss) Attributable to Parent 155M USD +66%
Earnings Per Share, Basic 3.21 USD/shares +67.2%
Earnings Per Share, Diluted 2.91 USD/shares +64.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 201M USD +13.9%
Accounts Receivable, after Allowance for Credit Loss, Current 138M USD +37.2%
Inventory, Net 115M USD +11.4%
Assets, Current 555M USD +36.2%
Deferred Income Tax Assets, Net 53.3M USD +38.2%
Property, Plant and Equipment, Net 289M USD +18.5%
Operating Lease, Right-of-Use Asset 31.4M USD +21.5%
Goodwill 3.15M USD -0.72%
Other Assets, Noncurrent 23.4M USD +26.1%
Assets 1.57B USD +103%
Accounts Payable, Current 36.5M USD +66.2%
Employee-related Liabilities, Current 25.4M USD +6.07%
Accrued Liabilities, Current 80.2M USD +19.8%
Liabilities, Current 255M USD +142%
Long-term Debt and Lease Obligation 594M USD +715%
Accrued Income Taxes, Noncurrent 6.07M USD -16%
Deferred Income Tax Liabilities, Net 201K USD -16.9%
Operating Lease, Liability, Noncurrent 28.7M USD +19.8%
Other Liabilities, Noncurrent 18M USD +18.5%
Liabilities 902M USD +301%
Accumulated Other Comprehensive Income (Loss), Net of Tax -8.77M USD -6.06%
Retained Earnings (Accumulated Deficit) 452M USD +52%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 672M USD +22.6%
Liabilities and Equity 1.57B USD +103%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 55.3M USD +36.9%
Net Cash Provided by (Used in) Financing Activities -13.6M USD -0.23%
Net Cash Provided by (Used in) Investing Activities 15.2M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 60.2M shares +2.94%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 56.9M USD +177%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 201M USD +13.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.63M USD +593%
Deferred Tax Assets, Valuation Allowance 20.5M USD +4.04%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 112M USD +20.6%
Operating Lease, Liability 33.6M USD +26%
Depreciation 6.82M USD +9.02%
Payments to Acquire Property, Plant, and Equipment 8.79M USD -7.22%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 154M USD +67.3%
Lessee, Operating Lease, Liability, to be Paid 41.5M USD +28%
Property, Plant and Equipment, Gross 540M USD +14.9%
Operating Lease, Liability, Current 3.94M USD +31.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.54M USD +47.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.61M USD +37.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +22.7%
Deferred Income Tax Expense (Benefit) -13.9M USD +12.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.88M USD +37.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.59M USD +53.7%
Deferred Tax Assets, Operating Loss Carryforwards 20.2M USD +0.68%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -13.1M USD +18.5%
Current Income Tax Expense (Benefit) 45.7M USD +16.1%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 12.5M USD -3.12%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.36M USD +51.6%
Operating Lease, Payments 5.11M USD +17.9%
Additional Paid in Capital 476M USD +4.26%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 1.91M USD +161%
Current Federal Tax Expense (Benefit) 42.7M USD +13.5%
Amortization of Intangible Assets 6.17M USD +2459%
Depreciation, Depletion and Amortization 32M USD +141%
Share-based Payment Arrangement, Expense 21.5M USD +13.4%
Deferred State and Local Income Tax Expense (Benefit) 1.54M USD +88.4%
Interest Expense 35.4M USD +1772%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%